13F-HR filed by GREAT POINT PARTNERS LLC
GREAT POINT PARTNERS LLC filed this 13F-HR for the quarter ended 2019-06-30, filed 2019-08-14, with 30 holding rows worth $900,806,000.
- Accession
- 0000930413-19-002313
- Filer
- CIK 1281446
- Filed
- 2019-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2019
A holdings report, 31 entries on the cover page, a total value of $900,806,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $900,806,000 with VALUE read as dollars, detected, 13F file number 028-11743. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerJAY JEFFREY R028-12517
- included managerKROIN DAVID028-13262
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 5,260,803 | $128,995,000 | dollars, detected | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 1,974,385 | $88,847,000 | dollars, detected | |
| ZOGENIX INC. | 98978L204 | Common Stock | 1,593,396 | $76,132,000 | dollars, detected | |
| AUDENTES THERAPEUTICS INC. | 05070R104 | Common Stock | 1,922,937 | $72,802,000 | dollars, detected | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 3,047,800 | $60,011,000 | dollars, detected | |
| ACCELERON PHARMA INC | 00434H108 | COM | 1,449,300 | $59,537,000 | dollars, detected | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 500,000 | $57,575,000 | dollars, detected | |
| TRICIDA INC | 89610F101 | COM | 1,423,998 | $56,191,000 | dollars, detected | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 1,500,000 | $40,095,000 | dollars, detected | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 300,000 | $30,900,000 | dollars, detected | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 300,000 | $30,900,000 | dollars, detected | put |
| ZYMEWORKS INC | 98985W102 | COM | 1,064,041 | $23,409,000 | dollars, detected | |
| RETROPHIN INC | 761299106 | COM | 1,003,600 | $20,162,000 | dollars, detected | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 175,000 | $18,025,000 | dollars, detected | call |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 1,676,250 | $17,718,000 | dollars, detected | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 350,000 | $15,327,000 | dollars, detected | |
| MILLENDO THERAPEUTICS INC | 60040X103 | COM | 1,288,093 | $14,891,000 | dollars, detected | |
| DERMIRA INC | 24983L104 | COM | 1,552,900 | $14,846,000 | dollars, detected | |
| ZOGENIX INC. | 98978L204 | Common Stock | 300,000 | $14,334,000 | dollars, detected | put |
| GENFIT S A | 372279109 | ADS | 694,253 | $13,711,000 | dollars, detected | |
| MENLO THERAPEUTICS INC | 586858102 | COM | 1,733,882 | $10,386,000 | dollars, detected | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 200,000 | $8,758,000 | dollars, detected | put |
| FOAMIX PHARMACEUTICALS LTD | M46135105 | SHS | 2,110,071 | $5,022,000 | dollars, detected | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 200,000 | $4,904,000 | dollars, detected | call |
| MOMENTA PHARMACEUTICALS INC | 60877T100 | COM | 342,064 | $4,259,000 | dollars, detected | |
| RVL PHARMACEUTICALS PLC | G6S41R101 | COM | 926,933 | $3,522,000 | dollars, detected | |
| PROTEOSTASIS THERAPEUTICS IN | 74373B109 | COM | 3,500,000 | $3,416,000 | dollars, detected | |
| FIVE PRIME THERAPEUTICS INC. | 33830X104 | Common Stock | 547,712 | $3,303,000 | dollars, detected | |
| ZAFGEN INC | 98885E103 | COM | 2,211,194 | $2,631,000 | dollars, detected | |
| STREAMLINE HEALTH SOLUTIONS | 86323X106 | COM | 130,137 | $197,000 | dollars, detected |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000930413-19-002313 | this filing | 2019-08-14 | acceptance time not in the bulk data set |